These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6555015)

  • 1. Single-dose cefonicid therapy for urinary tract infections.
    Pontzer RE; Krieger RE; Boscia JA; McNamee W; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1983 Jun; 23(6):814-6. PubMed ID: 6555015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose regimen of cefonicid for the treatment of uncomplicated infections of the lower urinary tract.
    Morgan SI; Pontzer RE; Cortez LM; Guice SL; Brannan W; Krieger RE; McNamee W; Boscia JA; Levison ME; Kaye D
    Rev Infect Dis; 1984; 6 Suppl 4():S844-6. PubMed ID: 6395274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of urinary tract infections in hospitalized patients: a double-blind comparison of cefonicid and cefamandole.
    Cox CE; Jacob LS
    Rev Infect Dis; 1984; 6 Suppl 4():S839-43. PubMed ID: 6395273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefonicid as therapy for uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
    Sanchez PL; Lancaster DJ; Berg SW; Kerbs SB; Harrison WO
    West J Med; 1984 Feb; 140(2):224-6. PubMed ID: 6428048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose treatment of uncomplicated gonococcal urethritis: a comparison of cefonicid and penicillin.
    Duncan WC; McBride ME
    Sex Transm Dis; 1982; 9(2):93-5. PubMed ID: 7101088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview: evaluation of cefonicid in infections of the urinary tract, lower respiratory tract, and skin and soft tissue.
    Kaye D
    Rev Infect Dis; 1984; 6 Suppl 4():S835-8. PubMed ID: 6522926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cefonicid (SK&F D-75073-Z2) in a single low dose in the treatment of complicated infections of the urinary tract].
    Salvadeo A; Hartwig J; Perduca M; Villa G
    G Ital Chemioter; 1984; 31(1-2):127-32. PubMed ID: 6468823
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of cefonicid and cefamandole for the treatment of community-acquired infections of the lower respiratory tract.
    Geckler RW; McCormack GD; Goodman JS
    Rev Infect Dis; 1984; 6 Suppl 4():S847-52. PubMed ID: 6395275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose treatment of uncomplicated gonorrhea: a comparison of cefonicid and penicillin.
    Duncan WC; McBride ME
    Rev Infect Dis; 1984; 6 Suppl 4():S875-9. PubMed ID: 6441224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefonicid: an overview of clinical studies in the United States.
    Jacob LS; Layne P
    Rev Infect Dis; 1984; 6 Suppl 4():S791-802. PubMed ID: 6395272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.
    Wallace RJ; Niefield SL; Waters S; Waters B; Awe RJ; Wiss K; Martin RR; Greenberg SB
    Antimicrob Agents Chemother; 1982 Feb; 21(2):231-5. PubMed ID: 7041813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose amoxicillin therapy with follow-up urine culture. Effective initial management for acute uncomplicated urinary tract infections.
    Savard-Fenton M; Fenton BW; Reller LB; Lauer BA; Byyny RL
    Am J Med; 1982 Dec; 73(6):808-13. PubMed ID: 6924538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN; Quintiliani R; Nightingale CH
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on antibiotic therapy. 30) Cefonicid].
    di Nola F
    Minerva Med; 1985 Apr; 76(16):819-25. PubMed ID: 4000526
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
    Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
    Pontzer RE; Kaye D
    Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
    Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of uncomplicated gonorrhea in women with single-dose cefonicid.
    Handsfield HH; Murphy VL
    Sex Transm Dis; 1985; 12(2):90-2. PubMed ID: 3923633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.